Back

Early electrical cardioversion for early recurrent atrial tachyarrhythmia after pulmonary vein isolation in atrial fibrillation: a global real-world analysis

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Epidemiology, prognosis, and outcomes in atrial fibrillation Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Leandra Serio

University of L'Aquila, Department of Clinical Medicine, Public Health, Life and Environmental Scien, L'Aquila (Italy)

6 More presentations in this session

Presentation thumbnail
Association between biological aging acceleration and adverse cardiovascular prognosis in atrial fibrillation patients: a multicenter real-world cohort study
Professor T. Liu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Integrated care improves outcomes in multimorbid patients with atrial fibrillation: insights from the MIRACLE-AF trial
Doctor M. Li (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Renal function and outcomes in subclinical atrial fibrillation: a prespecified analysis of the ARTESIA trial
Doctor R. Reddy (Durham, US)
Abstract Slides Video
Presentation thumbnail
Predictions of adverse outcomes using different renal function estimation formulas in patients with atrial fibrillation receiving direct oral anticoagulants
Doctor T. Chao (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Primary care physician continuity improve survival in patients with atrial fibrillation: a retrospective analysis of 15,000 patients with atrial fibrillation
Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology, prognosis, and outcomes in atrial fibrillation

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
ECG-derived atrial fibrillation organisation index, but not atrial fibrillatory rate, is associated with 30-day recurrence after cardioversion of the first-ever persistent atrial fibrillation episode
30 August 2026
thumbnail
Congress Session
Atrial tachycardia following atrial fibrillation ablation: insights and therapeutic strategies
12 April 2026
thumbnail
Congress Presentation
Objective randomised blinded investigation of therapeutic ablation versus cardioversion for persistent atrial fibrillation- outcomes of the feasibility
9 April 2024
thumbnail
Congress Presentation
Combined impact of diagnosis-to-ablation time and left atrial volume on one-year recurrence after first pulmonary vein isolation
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources